RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8
Frequently Asked Questions
What is Market Cap of RenovoRx Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. RenovoRx Inc market cap is $24.43M.
What is the 52-week high for RenovoRx Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. RenovoRx Inc 52 week high is $3.29 as of June 09, 2024.
What is the 52-week low for RenovoRx Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. RenovoRx Inc 52 week low is $0.5306 as of June 09, 2024.
What is RenovoRx Inc stock price today?
RenovoRx Inc stock price today is $1.02.
What was RenovoRx Inc stock price yesterday?
RenovoRx Inc stock price yesterday was $1.05.
What is the PE ratio of RenovoRx Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. RenovoRx Inc’s P/E ratio is -1.41.
What is the Price-to-Book ratio of RenovoRx Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. RenovoRx Inc P/B ratio is 9.7356.
What is RenovoRx Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. RenovoRx Inc's EBITDA is -1.47.
What is the 50-day moving average of RenovoRx Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. RenovoRx Inc 50-day moving average is $1.25.